Anne Armstrong is a Consultant Medical Oncologist at the Christie Hospital specialising in breast cancer. She has an interest in breast cancer in young women, including fertility preservation and pregnancy as well as survivorship issues. She is also actively involved in clinical and laboratory-based research, with a focus on immunotherapy research to optimise immunotherapeutic approaches in cancer. She is Principal Investigator for a broad portfolio of phase I-III studies within the breast disease group (Lead for investigational agents for triple-negative trials). She is the Chief Investigator for the IMpALA clinical trial, funded by Breast Cancer Now, a pre-operative window of opportunity study to look at the biological effect of aspirin in combination with immune checkpoint blockade.
She sits on the NRCN Breast Clinical Studies Group, is the Co-Chair for the NCRN Breast Clinical Studies Symptom Management Subgroup and was the Clinical Lead for the 2018 NICE Early and Locally Advanced Breast Cancer Guideline update.